Hindbrain catecholamine regulation of ventromedial hypothalamic nucleus glycogen metabolism during acute versus recurring insulin-induced hypoglycemia in male versus female rat.

6-hydroxydopamine Glycogen phosphorylase Glycogen synthase Recurrent insulin-induced hypoglycemia Sex differences Ventromedial hypothalamic nucleus

Journal

Endocrine and metabolic science
ISSN: 2666-3961
Titre abrégé: Endocr Metab Sci
Pays: England
ID NLM: 101776826

Informations de publication

Date de publication:
30 Jun 2021
Historique:
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: ppublish

Résumé

Ventromedial hypothalamic nucleus (VMN) glycogen metabolism affects local glucoregulatory signaling. The hindbrain metabolic-sensitive catecholamine (CA) neurotransmitter norepinephrine controls VMN glycogen phosphorylase (GP)-muscle (GPmm) and -brain (GPbb) type expression in male rats. Present studies addressed the premise that CA regulation of hypoglycemic patterns of VMN glycogen metabolic enzyme protein expression is sex-dimorphic, and that this signal is responsible for sex differences in acclimation of these profiles to recurrent insulin-induced hypoglycemia (RIIH). VMN tissue was acquired by micropunch-dissection from male and female rats pretreated by caudal fourth ventricular administration of the CA neurotoxin 6-hydroxydopamine (6OHDA) before single or serial insulin injection. 6-OHDA averted acute hypoglycemic inhibition of VMN glycogen synthase (GS) and augmentation of GPmm and GPbb protein expression in males, and prevented GPmm and -bb down-regulation in females. Males recovered from antecedent hypoglycemia (AH) exhibited neurotoxin-preventable diminution of baseline GS profiles, whereas acclimated GPmm and -bb expression in females occurred irrespective of pretreatment. RIIH did not alter VMN GS, GPmm, and GPbb expression in vehicle- or 6-OHDA-pretreated animals of either sex. VMN glycogen content was correspondingly unchanged or increased in males versus females following AH; 6-OHDA augmented glycogen mass in AH-exposed animals of both sexes. RIIH did not alter VMN glycogen accumulation in vehicle-pretreated rats of either sex, but diminished glycogen in neurotoxin-pretreated animals. AH suppresses baseline GS (CA-dependent) or GPmm/GPbb (CA-independent) expression in male and female rats, respectively, which corresponds with unaltered or augmented VMN glycogen content in those sexes. AH-associated loss of sex-distinctive CA-mediated enzyme protein sensitivity to hypoglycemia (male: GS, GPmm, GPbb; female: GPmm, Gpbb) may reflect, in part, VMN target desensitization to noradrenergic input.

Identifiants

pubmed: 33997825
doi: 10.1016/j.endmts.2021.100087
pmc: PMC8114938
mid: NIHMS1698737
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK109382
Pays : United States

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Références

Front Cell Neurosci. 2013 Apr 10;7:38
pubmed: 23596393
Diabetes Care. 2003 Jun;26(6):1902-12
pubmed: 12766131
Endocrinology. 2004 Apr;145(4):1750-9
pubmed: 14684600
Am J Physiol Regul Integr Comp Physiol. 2014 Apr 1;306(7):R457-69
pubmed: 24381179
Neuroendocrinology. 2001 Jun;73(6):369-77
pubmed: 11408778
Neuroscience. 2014 Oct 10;278:20-30
pubmed: 25084049
Brain Res. 2019 May 15;1711:48-57
pubmed: 30629946
Neuropeptides. 2017 Dec;66:25-35
pubmed: 28823463
Endocrinol Metab Clin North Am. 2010 Sep;39(3):641-54
pubmed: 20723825
J Neurochem. 2004 May;89(3):537-52
pubmed: 15086511
Glia. 2015 Jan;63(1):154-62
pubmed: 25130497
Endocrinology. 2004 Nov;145(11):5322-31
pubmed: 15308614
Neuroscience. 2018 May 21;379:103-114
pubmed: 29534973
Neuroscience. 2015 Apr 30;292:34-45
pubmed: 25701713
J Pharm Biomed Anal. 2020 Jan 30;178:112884
pubmed: 31606560
Endocrinology. 1974 Jun;94(6):1704-8
pubmed: 4857496
Adv Neurobiol. 2019;23:269-309
pubmed: 31667812
Neurochem Res. 2017 Jun;42(6):1629-1635
pubmed: 28083850
Cell Metab. 2011 Dec 7;14(6):724-38
pubmed: 22152301
J Neurosci Res. 2003 Oct 15;74(2):179-83
pubmed: 14515346
J Biol Chem. 2018 May 11;293(19):7099-7107
pubmed: 29483194
Endocrinology. 2008 Apr;149(4):1499-504
pubmed: 18187548
J Neurosci Res. 2003 Apr 1;72(1):25-32
pubmed: 12645076
Acta Neurobiol Exp (Wars). 2020;80(1):57-65
pubmed: 32214275

Auteurs

K P Briski (KP)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

Prabhat R Napit (PR)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

Ali Md Haider (A)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

A A Alshamrani (AA)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

A R Alhamyani (AR)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

Khaggeswar Bheemanapally (K)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

Mostafa M H Ibrahim (MMH)

School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, United States.

Classifications MeSH